Skip to main content
. 2020 Feb 28;6:2. doi: 10.1186/s40959-020-0058-1

Table 1.

Characteristics of the Cohort

Variables Median [IQR] or N (%)
Age, years 63 [59–66]
Female, n (%) 15 (60%)
Caucasian, n (%) 16 (64%)
African-American, n (%) 9 (36%)
Body mass index, kg/m2 26.4 [22.6–30.2]
Cancer Type
 Lung 15 (60%)
 Breast 10 (40%)
Time since Cancer Diagnosis, years 2.4 [1.1–3.9]
Prior chemotherapy 21 (84%)
Time since completion of chemotherapy, years 1.5 [0.5–3.0]
Time since completion of Radiotherapy, years 1.8 [0.4–3.6]

Hormonal modulating therapy

(Breast cancer only)

7 (28%)
MCRD, Gy 5.4 [3.7–14.7]
C-reactive protein, mg/L 3.0 [1.7–6.9]
%APMHR 93 [78–102]
LVEF, % 52 [47–61]
Doppler echo e’ velocity (cm/sec) 7.6 [7.0–9.6]
Delta LVOT VTI CO (L/min) 1.6 [1.5–1.9]

Data are listed as n (%) or median (interquartile range). Abbreviations: kg/m2 Kilograms per meter squared, MCRD Mean cardiac radiation dose, Gy Gray units, mg/L Milligrams per liter, %APMHR Percentage of age-predicted maximal heart rate, LVEF Left-ventricular ejection fraction, e’ Doppler early diastolic mitral annular velocity, cm/sec Centimeters per second, LVOT VTI CO Left-ventricular outflow tract velocity time integral cardiac output with exercise, L/min Liters per minute.